Novo Nordisk A/S ADR buy HSBC Holdings plc
Start price
01.10.25
/
50%
€49.90
Target price
01.10.26
-
Performance (%)
-12.22%
Price
23.12.25
€43.80
Summary
This prediction is currently active. The price of Novo Nordisk A/S ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.22%. This prediction currently runs until 01.10.26. The prediction end date can be changed by HSBC_Holdings_plc at any time. HSBC_Holdings_plc has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 6.569% | 6.569% |
| iShares Core DAX® | 0.224% | 2.457% |
| iShares Nasdaq 100 | 0.371% | -0.320% |
| iShares Nikkei 225® | 0.972% | -0.829% |
| iShares S&P 500 | 0.417% | -0.157% |
Comments by HSBC_Holdings_plc for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat